(509) 228-1000 WA
(208) 754-3100 ID

Hakan Kaya, MD

Share

back to doctors

Specialty

Autologous Stem Cell Transplantation

Medical Oncology and Hematology

Location:

SOUTH SPOKANE

 

  • Oncologist/Hematologist and Partner, Cancer Care Northwest
  • Director, Inland Northwest Myeloma/Lymphoma & Transplant Program
  • Clinical Professor, Elson S. Floyd College of Medicine Washington State University-Spokane
  • Clinical Associate Professor of Medicine, University of Washington School of Medicine-Spokane
  • Adjunct Professor, Voiland School of Chemical Engineering & Bioengineering, Washington State University-Pullman
     

Dr. Hakan Kaya has two passions in his professional life: 1) To provide state of the art care for multiple myeloma/lymphoma patients, and 2) To teach medical students/residents. He is a fellowship-trained transplant physician who has worked at Cancer Care Northwest since 2004. Dr. Kaya is the director of the Inland Northwest Myeloma/Lymphoma and Transplant Program. In addition to performing autologous stem cell transplantation, he provides the latest treatment options for myeloma and lymphoma patients who live in Eastern Washington, North Idaho and Western Montana. He frequently gives lectures to other oncologists around the country describing new advances in multiple myeloma. Dr. Kaya is a Clinical Professor at Washington State University Elson S. Floyd College of Medicine where he co-chairs the hematology/oncology course committee. He has been charged with developing and teaching the hematology-oncology course in this newly opened medical school. He has also been an active clinical faculty member at the University of Washington School of Medicine's Spokane campus since 2004, where he gives regular didactic lectures and provides clinical rotations for residents/medical students.

Outside of work, Dr. Kaya spends most of his time with his family. He also enjoys practicing martial arts (WTF certified 1st Degree Black Belt) which helps him to cope with daily stresses of being a cancer doctor.
 

Education

Medical School:

  • Ankara University School of Medicine; Ankara, Turkey

Residency & Internship:

  • University of Oklahoma Health Sciences Center (Internal Medicine); Oklahoma City, OK

Fellowship:

  •  Comprehensive Cancer Center of Wake Forest University (Medical Oncology, Hematology, and Bone Marrow Transplantation); Winston-Salem, NC (Three year fellowship training in Medical Oncology, Hematology, and Bone Marrow Transplantation. His fellowship included a one-year program entitled "Specialized Training in Hematopoietic Stem Cell Transplantation" which was designed to fulfill the guidelines for training (BMT fellowship) adopted by the American Society of Blood and Marrow Transplantation)

Other:

  • Clinical Professor, Elson S. Floyd College of Medicine Washington State University-Spokane

* Co-chairs the hematology/oncology course committee, charged with developing and teaching the hematology/oncology course in this newly opened medical school

* Member, Medical School Admissions Committee

  • Clinical Associate Professor of Medicine, University of Washington School of Medicine-Spokane

* Teaches residents and medical students.

* Provides clinical research opportunities for trainees.

* Gives regular didactic lectures in hematology/oncology subjects to internal medicine residency faculty, house staff, community physicians, and medical students.

* Educates Inland Northwest community by giving lectures to the public, appearing in local radio /TV shows, and being a resource to local journals.

  • Adjunct Professor, Voiland School of Chemical Engineering & Bioengineering, Washington State University-Pullman

* Consultant to WSU faculty in developing multiple myeloma related basic science projects

 

 
Certification
  •  American Board of Internal Medicine: Medical Oncology

 

Honors & Leadership
  • Best Doctors in America® list, specialty Medical Oncology & Hematology, 2015-2017
  • Recipient of Outstanding Clinical Faculty Award for 2006-2007 by Internal Medicine Residency Spokane
  • Recipient of the Assembly of Turkish American Associations (ATAA) 2004 Outstanding Achievement in the Arts/Sciences Award
  • Recipient of Chief Residents’ Award for Outstanding Service to the Residency Program, University of Oklahoma
  • Recipient of Best Poster Presentation Award at the Department of Medicine House Staff Research Day, University of Oklahoma, Department of Medicine
  • Recipient of Special Recognition Award in Poster Presentation in allogeneic bone marrow transplantation at the American College of Physicians-Oklahoma Chapter Annual Meeting
  • Best Student Research Award in Basic Sciences, Ankara University School of Medicine    
  • Scored among the top 0.1 % students out of 500,000 examiners who took the university admission test in 1986 in Turkey
  • In the local media:

http://washington.providence.org/~/media/files/providence/hospitals/wa/phc/health%20care%20professionals/pulsemagazine.pdf/
http://washington.providence.org/~/media/files/providence/hospitals/wa/phc/heart%20beat/heartbeat_20143.pdf/
http://www.spokesman.com/stories/2013/feb/07/patient-celebrates-birthday/
http://www.spokesman.com/stories/2011/jan/18/care-close-to-home/

 

Research


Book Chapter

  • Kaya H, Hall MC, Torti FM. Defining treatment failure after local treatment, restaging. In: Kantoff PW, Carroll P, D’Amico A (eds): Prostate Cancer. Lippincott Williams Publishers, 2002


Selected Abstracts

Presented at the annual meeting of the American Society of Clinical Oncology June 2014.

Presented at the annual meeting of American Society of Hematology, December 2013

Presented at the annual meeting of American Society of Hematology, December 2013

Presented at the annual meeting of American Society of Hematology, December 2011

  • Jawed I, Lee CM, Tward JD, Macdonald KO, Martincic D, Kaya H. Survival Outcomes for Multiple Myeloma Over Three Decades: A Surveillance, Epidemiology, and End Results (SEER) Analysis. Oral presentation at 2007 ASCO Annual Meeting.
  • Vudarla N, Jawed I, Kaya H, Tward JD, Macdonald OK, Martincic D, Gaffney DK, Shivnani AT, Odom-Maryon TL, Lee CM. Survival and secondary malignancy rates for adjuvant radiation therapy versus observation in stage I testicular seminoma: A Surveillance, Epidemiology, and End Results (SEER) analysis. Oral presentation at 2007 ASCO Annual Meeting.
  • Kaya H, Manning C, Case D, Hurd D. Cytokine Gene Polymorphism in Allogeneic Bone Marrow Transplant Patients and Donors. Biol Blood Marrow Transplant, 2000
  • Kaya H, Acastomiado J, et al. A Phase II trial of Navelbine, Adriamycin, and Prednisone Combination Chemotherapy in Hormone Refractory Prostate Cancer. Proc Am Soc Clin Oncol 19, 2000
  • Acostamadiedo J, Case D, Perry J, Kaya H, et al. Randomized Trial of G-CSF Primed Autologous Bone Marrow vs. G-CSF Primed Peripheral Blood Stem Cells as Hematopoietic Support after high Dose Cyclophosphamide Thiotepa, and Carboplatin in Poor Prognosis Breast Cancer. Proc Am Soc Clin Oncol 19, 2000
  • Keung YK, Kaya H, Radford JE, et al. Adjuvant use of Rituximab after autologous peripheral blood stem cell transplantation for advanced Non-Hodgkin’s lymphoma. Blood 1999;94:S401b
  • Kute TE, Kaya H, Radford JE, et al. Is NM 23 expression related to metastatic disease in breast cancer? Lab Invest 79:24A, 1999
  • Kaya H, Case D, Perry J, et al. Updated results of multi-modality therapy including high-dose cyclophosphamide, thiotepa, carboplatin and autologous transplant for locally advanced breast cancer. Proc Am Soc Clin Oncol 17, 1998
  • Kaya H, Confer D. Allogeneic bone marrow transplantation: Comparison of graft-versus host disease, relapse and disease free survival in related and unrelated donor transplants Program Book, American College of Physicians-Oklahoma Chapter Annual Scientific Meeting, 1995